CIK 0001630627
- Accelerated filer
TREACE MEDICAL CONCEPTS, INC.
Sign in to watch- Ticker
- TMCI
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- FL
- Entity type
- Operating
- EIN
- 471052611
- Phone
- +1 904-373-5940
- Business address
- 100 PALMETTO PARK PLACE, PONTE VEDRA, FL, 32081
- Open-market buys, last 90 days
- $47,731
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$47,731. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-11-17 | TREACE JAMES T Director | Sale | −25,000 | $20.33 | $508K | 2,130,258 |
| 2021-11-16 | TREACE JAMES T Director | Sale | −25,000 | $20.86 | $522K | 2,155,258 |
| 2021-11-15 | TREACE JAMES T Director | Sale | −19,485 | $20.41 | $398K | 2,185,773 |
| 2021-11-15 | TREACE JAMES T Director | Sale | −5,515 | $21.41 | $118K | 2,180,258 |
| 2021-11-12 | TREACE JAMES T Director | Gift | −600,000 | 1,130,258 | ||
| 2021-11-10 | Scanlan Sean F. SVP, Marketing | Exercise or conversion | +25,000 | $1.57 | $39K | 25,000 |
| 2021-11-10 | Scanlan Sean F. SVP, Marketing | Sale | −24,560 | $21.53 | $529K | 440 |
| 2021-11-10 | Scanlan Sean F. SVP, Marketing | Sale | −440 | $22.20 | $10K | 0 |
| 2021-11-10 | Scanlan Sean F. SVP, Marketing | Exercise or conversion · Stock Option (Right to Buy) | −25,000 | 57,524 | ||
| 2021-10-27 | TREACE JAMES T Director | Gift | −200,000 | 1,930,258 | ||
| 2021-10-27 | TREACE JAMES T Director | Gift | −200,000 | 1,730,258 | ||
| 2021-10-22 | Treace John T. Chief Executive Officer | Sale | −57,534 | $20.74 | $1.2M | 5,753,135 |
| 2021-10-22 | Treace John T. Chief Executive Officer | Sale | −555 | $21.16 | $12K | 5,752,580 |
| 2021-10-21 | Treace John T. Chief Executive Officer | Sale | −34,325 | $19.89 | $683K | 5,852,428 |
| 2021-10-21 | Treace John T. Chief Executive Officer | Sale | −26,701 | $20.67 | $552K | 5,825,727 |
| 2021-10-21 | Treace John T. Chief Executive Officer | Sale | −2,768 | $21.49 | $59K | 5,822,959 |
| 2021-10-21 | Treace John T. Chief Executive Officer | Sale | −8,207 | $23.07 | $189K | 5,814,752 |
| 2021-10-21 | Treace John T. Chief Executive Officer | Sale | −4,044 | $23.86 | $96K | 5,810,708 |
| 2021-10-21 | Treace John T. Chief Executive Officer | Sale | −39 | $24.50 | $956 | 5,810,669 |
| 2021-10-20 | Treace John T. Chief Executive Officer | Sale | −22,612 | $24.79 | $561K | 5,894,968 |
Page 25 of 28 · 560 trades